We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Smart Cells International Launches new Stem Cell Collection Process

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Smart Cells International Launches new Stem Cell Collection Process"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
A new method of collecting and storing stem cells has been launched by Smart Cells International Ltd, the UK's longest- established stem cell banking service.

The process allows the collection of mesenchymal stem cells (MSCs) from the umbilical cord tissue.

"MSCs have been studied extensively and the potential therapeutic value they offer for treatment in a wide range of diseases is increasing all the time," said Shamshad Ahmed, SCI Chief Executive.

"Until recently, the umbilical cord was thrown away, but scientific advances mean stem cells can now be harvested from the cord itself, and stored. We call this service 'Smart Cord'.

"Clinical trials are underway evaluating MSCs from cord tissue for the treatment of Parkinson's Disease, Multiple Sclerosis, Diabetes and Stroke, skeletal muscle injury, limb ischemia, and retinal nerve degeneration.

"Advancements in scientific technology to harness the potential of umbilical cord tissue, which is now widely accepted to be a rich source of mesenchymal stem cells (MSCs) means a much wider proportion of the world's population can benefit from stem cell collection."

The procedures used to procure and cryopreserve this rich source of stem cells have been developed in-house by the Smart Cells team.  By offering this service Smart Cells is achieving a considerable technological milestone offering customers the chance of storing an even greater pool of stem cells for future use.

Shamshad Ahmed, Chief Executive of Smart Cells, said: "We have developed the technology to store umbilical cord tissue-mesenchymal stem cells. Umbilical cord blood is a rich source of hematopoietic stem/progenitor cells and does not contain mesenchymal progenitors. We have established state of the art facilities for efficient processing and long term storage of cord tissue. "Just as with the cord blood, parents should also be given the information about the benefits of storing their child's cord tissue stem cells."

Just as with cord blood, the collection procedure is a quick, safe, non-invasive and simple procedure. Once delivered to the laboratory facilities, the cord tissue can be efficiently processed and prepared for long term storage, the company says.